Mayo Clinic - Rochester Minnesota

Rochester, Minnesota 55905

2 studies enrolling now · 3 studies all time

What they study most

Bladder Cancer, Intermediate Risk Non-Muscle Invasive Bladder Cancer, Low-grade Upper Tract Urothelial Carcinoma

Studies at this site

• Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
• Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis — Recruiting now
• ADSTILADRIN Early Utilization and Outcomes in the Real World Setting — Stopped early